In her lab at Children’s Hospital of Philadelphia, Dr. Yael Mossé leads an international team of researchers studying MYCN, a treatment-elusive mutated gene that drives cancer. At City of Hope in Los Angeles, Dr. Linda Malkas is working on a liquid formulation of promising cancer drug she developed, so that drug can be trialed in children as well as adults. In Memphis, Dr. Rebecca Gardner is working to make CAR T immunotherapy more effective, more accessible, and more equitable for kids with cancer. In her Vienna, Austria lab, Dr. Anna Obeneuf combines biology with cutting-edge technology... Read More
The Childhood Cancer Blog
Welcome to The Childhood Cancer Blog
from Alex's Lemonade Stand Foundation!
No one expects to find themselves in the childhood cancer world — Keren Fitzgerald certainly did not. Her son Cole, who passed away at age 19, was originally diagnosed with neuroblastoma when he was just 3 years old. In those early days, she had to Google “neuroblastoma” to understand all the new terminology. That search led her to Alex’s Lemonade Stand Foundation and helped give the Fitzgerald family a purpose outside of the hospital walls: to advocate for childhood cancer.
They know first-hand how desperately safer treatments and cures are needed. When Cole was diagnosed 15... Read More
The number of children diagnosed with cancer each year, around the world, is hard to estimate. The best estimate, from the World Health Organization, is more than 400,000. But, without a comprehensive, global childhood cancer registry, knowing the true numerical impact is difficult.
But what we do know is that childhood cancer happens everywhere. It happens in the United States and it happens in Germany and it happens in Kenya. There is not one country in the world that is untouched by childhood cancer. A study in 2017 estimated that each year cancer stole 11.5 million years of... Read More
